US Edition
Longhorn impacting global health challenges by tackling bacterial toxins with vaccine and diagnostics solutions - BioTuesdays
Summary by biotuesdays.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Longhorn impacting global health challenges by tackling bacterial toxins with vaccine and diagnostics solutions - BioTuesdays
By Melane Sampson Jeff Fischer, Co-founder and President Closely held Longhorn Vaccines and Diagnostics is developing peptide vaccines and monoclonal antibodies aimed at preventing and reducing the global burden of medical conditions caused by key bacterial toxins, including both pandemic and endemic diseases in humans and animals. “We are advancing a robust pipeline of broad based solutions to better diagnose, prevent, and treat a wide range o…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
